NERV · Minerva Neurosciences, Inc.
$4.58
+0.66 (+16.84%)
At close · Aug 14
Market Cap
$218.68M
Shares
47.75M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-31 | Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series | 10% Stockholder | 8,798 | 2026-03-31 | Canaccord Genuity, Inc. |
| 2026-03-31 | Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds | 10% Stockholder | 31,808 | 2026-03-31 | Canaccord Genuity, Inc. |
| 2026-03-31 | Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds | 10% Stockholder | 19,838 | 2026-03-31 | Canaccord Genuity, Inc. |
| 2026-03-10 | Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series | 10% Stockholder | 12,456 | 2026-03-10 | Canaccord Genuity, Inc. |
| 2026-03-10 | Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds | 10% Stockholder | 424,278 | 2026-03-10 | Canaccord Genuity, Inc. |
| 2026-03-10 | Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds | 10% Stockholder | 264,615 | 2026-03-10 | Canaccord Genuity, Inc. |
Showing 1–6 of 6 filings
Key facts
CIK
1598646
CUSIP
603380205
13F (30d)
57 filings
55 filers
Visit website
Investor relations